November 2, 2026 · Journal of hepatology · DOI: 10.1016/j.jhep.2026.09.028

Liver biopsy confirms precise and efficient correction of SERPINA1 after in vivo Base Editing in a Patient with Alpha-1 Antitrypsin Deficiency.

Listen to this summary

This case report describes the first clinical assessment of in vivo base editing for alpha-1 antitrypsin deficiency (PI*ZZ genotype), asking whether the therapy can directly correct the SERPINA1 mutation in the liver. A liver biopsy taken 10 weeks after treatment in a 66-year-old patient showed about 54-57% correction of PI*ZZ alleles, with no detectable bystander or off-target editing, no hepatic inflammation, and transient transaminase elevation that resolved. Sustained circulating levels of biologically active AAT over follow-up support the feasibility of this approach, though findings come from a single patient.

Simon Alexander Krooss, Taihua Yang, Qinggong Yuan, Nora Drick, Malte Sgodda, Julia Held, Patrick Behrendt, Bjoern Hartleben, Rembert Koczulla, Xiaoying Ma, Ying Liu, Heiner Wedemeyer, Sabina Janciauskiene, Nataliya Di Donato, Tobias Cantz, ZiJun Wang, Yuxuan Wu, Marius Hoeper, Qiang Xia, Michael Ott

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play